Imperial College London

Professor Tom Bourne

Faculty of MedicineDepartment of Metabolism, Digestion and Reproduction

Chair in Gynaecology
 
 
 
//

Contact

 

+44 (0)20 3313 5131t.bourne Website

 
 
//

Location

 

Early pregnancy and acute gynaecologyInstitute of Reproductive and Developmental BiologyHammersmith Campus

//

Summary

 

Awards

External Positions

  • Chair, Honours Committee, International Society for Ultrasound in Obstetrics and Gynecology, 2022
  • Chief Executive Office (CEO), CEO of the International Ovarian Tumor Anlaysis Group activities - including education and trial portfolio, The international Ovarian Tumor Analysis Group. The International Ovarian Tumor Analysis (IOTA) group was founded in 1999 by Dirk Timmerman, Lil Valentin and Tom Bourne. Its first aim was to develop standardized terminology. In 2000, IOTA published a consensus statement on terms, definitions and measurements to describe the sonographic features of adnexal masses, which is now widely used. IOTA now covers a multitude of studies examining many aspects of gynecological ultrasonography within a network of contributing centers throughout the world.Having agreed on standardized terminology, the principal IOTA investigators from different centers prospectively collected a large cohort of patients with a persistent adnexal mass. Accurate preoperative discrimination between benign and malignant adnexal masses is known to be of pivotal value in clinical practice. Research has focused on the development of predictive models to estimate the risk of malignancy. This database and the close involvement of the civil engineering department at KU Leuven has enabled both previously developed prediction models to be tested and novel prediction models to be developed and externally validated.Currently IOTA is engaged in several new studies. The group is investigating the long-term behavior of expectantly managed adnexal pathology (IOTA phase 5). This will answer important questions about complications and malignant transformation in masses that are left in situ. Studies are being carried out to determine the best second stage test for masses that are difficult to classify by the existing models, for instance by MRI (IOTA-MRI). Other studies focus on the identification of new potential biomarkers (trans-IOTA) to be incorporated in diagnostic models.Today there are over 50 clinical units contributing to IOTA studies, nearly every continent is represented. The group is multidisciplinary and involves gynecologists, radiologists, oncologists – as well as physicists and biologists. The group believes that good communication between all these disciplines is how ideas can be turned into improvements for patients. 2015 marks new developments for IOTA. The culture of IOTA is to be transparent and open to new collaborators. Interested units should not hesitate to contact us, as we are always interested in new ideas!, 2020
  • President, ISUOG Executive Committee and President of the Society, ISUOG - the International Society for Ultrasound in Obstetrics and Gynecology. ISUOG is the leading international society of professionals in ultrasound for obstetrics and gynaecology. Beginning in 1991 with the first issue UOG Journal and the first World Congress, ISUOG has now grown to over 14,000 members in 127 countries. It runs the highest ranked journal in the specialty with an impact factor of just under 5.7. ISUOG runs numerous educational courses, an annual scientific meeting which this year had over 3000 attendees, as well as outreach to low income countries., 2020 - 2022
  • Committee Member, Consensus Paper Development Committee of European Society for Gynaecological Endoscopy (ESGE), European Society for Gynaecological Oncology (ESGO). International Ovarian Tumor Analysis group (IOTA) and International Society for Ultrasound in Obstetrics and Gynecology - for the Preoperative Diagnosis of Ovarian Masses, European Society for Gynaecological Endoscopy (ESGE), European Society for Gynaecological Oncology (ESGO). International Ovarian Tumor Analysis group (IOTA) and International Society for Ultrasound in Obstetrics and Gynecology, 2020
  • Chair, RCOG Early pregnancy clinical studies group, Royal College of Obstetricians and Gynaecologists, 2017
  • Committee Member, RCOG Supporting our Doctors Task Force, Royal College of Obstetricians and Gynaecologists, 2017
  • Committee member, American College of Radiology O'RADS committee - developing new criteria for the diagnosis of ovarian cancer in the USA, American College of Radiology, 2016 - 2017
  • Director of Early Pregnancy Research, Management Committee Tommys National Centre for Miscarriage Research, Tommy's National Early Miscarriage Research Centre, 2016
  • Member of committeeThe American College of Radiology is sponsoring a committee for the development of “O-Rads”, an acronym for an Ovarian-Adnexal Imaging-Reporting-Data System. “O-Rads” will be a quality assurance tool for the standardized description of ovarian/adnexal pathology. The creation of a standardized lexicon will permit the development of a practical, uniform vocabulary for describing the imaging characteristics of ovarian masses, with the ultimate goal of applying it to a risk stratification classification for consistent follow up and management in clinical practice. We expect that the work of the committee will be the basis for one or more evidence-based white papers dealing with an adnexal mass lexicon and risk classification system., The American College of Radiology “O-Rads” committee - “O-Rads” will be a quality assurance tool for the standardized description of ovarian/adnexal pathology, American College of Radiology, 2015
  • President, Executive Committee Association of Early Pregnancy Units, The Association of Early Pregnancy Units in the UK, 2014
  • Member of consensus group to develop new guidelines for the diagnosis of ovarian cancer and classification of ovarian cysts in North America, International Consensus Conference on Adnexal Masses: State of the Science, The American Institute for Ultrasound in Medicine (AIUM), 2014
  • Scientific committee member, Congress planning committee for the RCOG 2016 World congress in Birmingham on 20 – 22 June 2016., Royal College of Obstetricians and Gynaecologists (RCOG), 2014 - 2016
  • Member of the consensus group and speaker, SRU Consensus Group to define guidelines for diagnosing early pregnancy failure in the USA, Society of Radiologists in Ultrasound (SRU) in the United States, 2012 - 2012
  • Member, Ultrasound advisory group, Royal College ob Obstetricians and Gynaecologists, 2012
  • Expert Advisor, NICE: Expert advisor to the bleeding in early pregnancy guideline development group, NICE, 2011 - 2012
  • committee member, RCOG ultrasound education committee, Royal College of Obstetricians and Gynaecologists (RCOG), 2011
  • Member of steering committee, International Endometrial Tumor Analysis Steering Committee, International endometrial tumor analysis trial, 2010
  • committee member, Royal College of Obstetricians and Gynaecologists Gynaecology ultrasound training committee, Royal College of Obstetricians and Gynaecologists, 2010 - 2015
  • Trustee and Medical Advisor, Board of Trustees Ectopic Pregnancy Trust, The Ectopic Pregnancy Trust, 2009 - 2020
  • Member of the Board, ISUOG Board, International Society for Ultrasound in Obstetrics and Gynecology, 2006 - 2014
  • Board member, Association of early pregnancy units- Board, Association of Early Pregnancy Units, 2005 - 2011
  • Committee member, Scientific Committee for International Society for Ultrasound in Obstetrics and Gynecology, International Society for Ultrasound in Obstetrics and Gynecology, 2003 - 2014
  • Member of steering committee, International Ovarian Tumor Analysis Steering committee, International Ovarian Tumor Analysis Trial, 1998
  • Treasurer, ISUOG executive committee, International Society for Ultrasound in Obstetrics and Gynecology (ISUOG)

Membership of Professional Bodies

Links with Other Academic Bodies

Industrial Connections

  • Roche Diagnostics, 1. Use of biomarkers in early pregnancy2. Characterisation of ovarian masses
  • Samsung Medison, Loan ultrasound equipment to carry out studies on the characterisation of ovarian tumors

Fellowships

Editorial Boards